Delivery Order SPE2DB24D3013-SPE2DB26FFGES
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $5,144.31. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $6,461.42. This firm fixed-price delivery order is scheduled for completion by November 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $6,752.39. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $20,970.95. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections with a ceiling value of $16,765.08. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order contract valued at $3,813.85 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. This competitive, firm fixed-price delivery order is set to be completed by July 28, 2025, with performance occurring at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order issued under a larger contract vehicle supporting the federal medical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 ml pen injections, with a ceiling value of $2,853.49 and an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order under a non-competitive, non-set-aside award, with performance directed to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of...
- The Defense Logistics Agency awarded a $4,839.72 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract is expected to be completed by September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections, with a contract ceiling value of $5,721.62. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order...
- The Defense Logistics Agency awarded a $4,451.71 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of November 7, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFGESDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $6,841.77. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under a child contract vehicle, leveraging the company's extensive federal pharmaceutical supply infrastructure. This delivery order falls within AmerisourceBergen Drug Corp's broader pharmaceutical distribution role supporting military and federal healthcare systems. As a major pharmaceutical distributor, the company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. Through this umbrella contract and related delivery orders, AmerisourceBergen supplies essential medications, vaccines, and medical supplies to the Defense Health Agency and other federal healthcare programs, including specialized pharmaceutical products across multiple therapeutic domains. The small delivery order for Zepbound reflects the company's role in fulfilling specific, time-sensitive pharmaceutical procurement requirements for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 11/6/25 |